| __timestamp | ACADIA Pharmaceuticals Inc. | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 111110000 |
| Thursday, January 1, 2015 | 73869000 | 129714000 |
| Friday, January 1, 2016 | 99284000 | 139574000 |
| Sunday, January 1, 2017 | 149189000 | 218502000 |
| Monday, January 1, 2018 | 187163000 | 322876000 |
| Tuesday, January 1, 2019 | 240385000 | 427320000 |
| Wednesday, January 1, 2020 | 319130000 | 523667000 |
| Friday, January 1, 2021 | 239415000 | 491707000 |
| Saturday, January 1, 2022 | 361575000 | 515083000 |
| Sunday, January 1, 2023 | 351619000 | 241294000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, ACADIA Pharmaceuticals Inc. and Galapagos NV have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Galapagos NV consistently outpaced ACADIA in R&D spending, peaking in 2020 with a 370% increase from 2014. However, by 2023, Galapagos's R&D expenses dropped by over 50% from its 2020 high, reflecting a strategic pivot or market adaptation. In contrast, ACADIA's R&D spending grew steadily, with a notable 480% increase from 2014 to 2022, before a slight dip in 2023.
These trends highlight the dynamic nature of biotech investments, where strategic shifts can significantly impact a company's innovation trajectory and market position.
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Gilead Sciences, Inc. and Galapagos NV
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Galapagos NV
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Galapagos NV
R&D Spending Showdown: Mesoblast Limited vs Galapagos NV